The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dr Nikhil Kelkar

DR. NIKHIL KELKAR, JOINT MANAGING DIRECTOR National Stock Exchange of India Limited BSE Limited Listing & Compliance Department Listing Department Exchange Plaza, C-1, Block G, Floor 25, P J Towers, Bandra Kurla Complex, Bandra (East), Dalal Street, Mumbai – 400001 Mumbai – 400051, Maharashtra, India. Maharashtra, India. SYMBOL: HEXAGON Scrip Code: 544785 Sub: Submission of Disclosure Under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers), Regulations, 2011 Dear Sir/Madam, With reference to Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers), Regulations, 2011, Please find enclosed herewith Disclosure Under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers), Regulations, 2011 regarding acquisition of 16400 Equity Shares. This is for your information and records. Thanking you, Yours faithfully, Dr. Nikhil Kelkar Promoter & Joint Managing Director Encl: As above CC: The Company Secretary & Compliance Officer Hexagon Nutrition Limited 404, Global Chambers, Off Link Road, Andheri (West), Mumbai – 400053 DR. NIKHIL KELKAR, JOINT MANAGING DIRECTOR DISCLOSURES UNDER REGULATION 29(2) OF SEBI (SUBSTANTIAL ACQUISITION OF SHARES AND TAKEOVERS) REGULATIONS, 2011 HEXAGON NUTRITION LIMITED Name of the Target Company (TC) DR. NIKHIL KELKAR Name(s) of the acquirer and Persons Acting in Concert (PAC) with the acquirer Whether the acquirer belongs to Promoter/Promoter group 1. National Stock Exchange of India Limited Name(s) of the Stock Exchange(s) where the shares of TC 2. BSE Limited are Listed Number % w.r.t. total % w.r.t. share/voting total diluted Details of the acquisition / disposal as follows capital share/voting wherever capital of the applicable(*) TC (**) Before the acquisition under consideration, holding of : a) Shares carrying voting rights DR. NIKHIL ARUN KELKAR 2,12,16,068 17.26 % 17.26 % b) Shares in the nature of encumbrance - - - (pledge/ lien/ non-disposal undertaking/ others) c) Voting rights (VR) otherwise than by shares - - - d) Warrants/convertible securities/any other - - - instrument that entitles the acquirer to receive shares carrying voting rights in the T C (specify holding in each category) 2,12,16,068 17.26 % 17.26 % e) Total (a+b+c+d) Details of acquisition/sale a) Shares carrying voting rights acquired DR. NIKHIL ARUN KELKAR 16,400 0.01 % 0.01% b) VRs acquired /sold otherwise than by shares - - - c) Warrants/convertible securities/any other - - - instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) acquired/sold d) Shares encumbered / invoked/released by the - - - acquirer e) Total (a+b+c+/-d) 16,400 0.01 % 0.01% DR. NIKHIL KELKAR, JOINT MANAGING DIRECTOR Number % w.r.t.total % w.r.t. total After the acquisition/sale, holding of: share/voting diluted capital share/voting wherever capital of the applicable(*) TC (**) a) Shares carrying voting rights DR. NIKHIL ARUN KELKAR 2,12,32,468 17.27 % 17.27 % b) Shares encumbered with the acquirer - - - c) VRs otherwise than by shares - - - d) Warrants/convertible securities/any other - - - instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) after acquisition 2,12,32,468 17.27 % 17.27 % e) Total (a+b+c+d) OPEN MARKET Mode of acquisition / sale (e.g. open market / off-market / public issue / rights issue / preferential allotment / inter-se transfer etc). 17th August 2026 Date of acquisition / sale of shares / VR or date of receipt of intimation of allotment of shares, whichever is applicable 12,29,18,109 Equity share capital / total voting capital of the TC before the said acquisition / sale 12,29,18,109 Equity share capital/ total voting capital of the TC after the said acquisition / sale 12,29,18,109 Total diluted share/voting capital of the TC after the said acquisition (*) Total share capital/ voting capital to be taken as per the latest filing done by the company to the Stock Exchange under Clause 35 of the listing Agreement. (**) Diluted share/voting capital means the total number of shares in the TC assuming full conversion of the outstanding convertible securities/warrants into equity shares of the TC. Signature of the acquirer Dr. Nikhil Kelkar Promoter and Joint Managing Director Date: 18/08/2026